Anastomotic stenosis of an arteriovenous fistula is often amenable to percutaneous intervention (angioplasty and stenting) and unlikely to be complicated by infection. A 69-year-old man underwent pre-emptive arteriovenous fistula construction that required interval placement of a covered stent for juxta-anastomotic stenosis. The patient presented 1 year after the intervention with systemic sepsis that required stent graft explantation and revision. This is a unique case report showing an infected stent graft, placed to restore secondary patency, that was later found to be the source of bacteremia and septic pulmonary emboli. (J Vasc Surg Cases and Innovative Techniques 2019;5:195-6.) Keywords: Infected stent graft; AVF stent graft; Covered stent infection Anastomotic stenosis of an arteriovenous fistula (AVF) is often amenable to percutaneous intervention. Endovascular techniques such as angioplasty and stenting are the most common methods of salvage for hemodialysis access and are unlikely to be complicated by infection. Although fabric-covered stents are available, they are less frequently required. Clinical examination of the fistula demonstrated a short 3-cm area in the proximal forearm that was mildly tender and indurated.
Anastomotic stenosis of an arteriovenous fistula (AVF) is often amenable to percutaneous intervention. Endovascular techniques such as angioplasty and stenting are the most common methods of salvage for hemodialysis access and are unlikely to be complicated by infection. Although fabric-covered stents are available, they are less frequently required.
1,2

CASE REPORT
A 69-year-old man with transitional cell carcinoma of the ureter underwent a left radical nephrectomy and cystectomy. He was referred to the vascular surgery service for an AVF before scheduled resection of a contralateral right renal cell carcinoma. Therefore, a right radiocephalic AVF was constructed and matured before oncologic resection. The right radical nephrectomy was uncomplicated, and hemodialysis was started immediately postoperatively without insertion of a hemodialysis catheter. 
DISCUSSION
AVF infection is extremely rare (incidence rate of <1%), hence making it optimal for use in a population of patients in whom infections are the second leading cause of death. 3, 4 Inserting covered stents in autogenous fistulas theoretically converts the access to a prosthetic graft, reducing the infectious advantage and counteracting Fistula First. We hypothesize that this stent graft infection developed from translocation of skin flora introduced through repeated percutaneous access. Recurrent bacteremia from this endoluminal source resulted in dissemination of bacterial colonies, septicemia, and pulmonary parenchymal abscesses. Infection associated with covered stents in the setting of autogenous hemodialysis access is rare. The literature lacks sufficient data to identify the true incidence of this complication.
CONCLUSIONS
A stent graft that restored secondary patency for an autogenous AVF was initially unsuspected as the nidus for bacteremia and septic pulmonary emboli. The actual source was unrecognized for months. The infections resolved after excision of the covered stent graft with preservation of the AVF, which continues to function well.
